Duncker Streett & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$163K Sell
1,876
-33
-2% -$3.16K 0.03% 247
2025
Q4
$183K Sell
1,909
-9
-0.5% -$874 0.03% 235
2025
Q3
$183K Buy
1,918
+17
+0.9% +$1.56K 0.03% 238
2025
Q2
$166K Sell
1,901
-247
-11% -$20.9K 0.03% 242
2025
Q1
$193K Buy
2,148
+29
+1% +$2.6K 0.04% 229
2024
Q4
$169K Sell
2,119
-1,251
-37% -$108K 0.03% 241
2024
Q3
$303K Sell
3,370
-934
-22% -$78.6K 0.06% 198
2024
Q2
$339K Sell
4,304
-1,662
-28% -$136K 0.07% 190
2024
Q1
$520K Sell
5,966
-536
-8% -$45.7K 0.1% 151
2023
Q4
$536K Sell
6,502
-1,307
-17% -$99.6K 0.11% 143
2023
Q3
$612K Sell
7,809
-23
-0.3% -$1.93K 0.14% 125
2023
Q2
$690K Buy
7,832
+13
+0.2% +$1.12K 0.15% 127
2023
Q1
$630K Sell
7,819
-594
-7% -$48.4K 0.15% 129
2022
Q4
$654K Sell
8,413
-1,831
-18% -$148K 0.16% 130
2022
Q3
$827K Sell
10,244
-1,614
-14% -$145K 0.21% 109
2022
Q2
$1.06M Sell
11,858
-1,775
-13% -$180K 0.26% 103
2022
Q1
$1.51M Sell
13,633
-1,483
-10% -$157K 0.3% 94
2021
Q4
$1.56M Buy
15,116
+51
+0.3% +$5.91K 0.27% 103
2021
Q3
$1.89M Sell
15,065
-1,165
-7% -$151K 0.36% 90
2021
Q2
$2.02M Sell
16,230
-10,361
-39% -$1.3M 0.37% 88
2021
Q1
$3.14M Sell
26,591
-4,920
-16% -$577K 0.6% 56
2020
Q4
$3.69M Buy
31,511
+704
+2% +$77.5K 0.71% 45
2020
Q3
$3.2M Buy
30,807
+406
+1% +$40.8K 0.7% 41
2020
Q2
$2.79M Sell
30,401
-906
-3% -$86.9K 0.66% 46
2020
Q1
$2.82M Sell
31,307
-10
-0% -$1.06K 0.75% 42
2019
Q4
$3.55M Sell
31,317
-610
-2% -$66.9K 0.75% 42
2019
Q3
$3.47M Buy
31,927
+300
+0.9% +$31.3K 0.81% 36
2019
Q2
$3.08M Buy
31,627
+26
+0.1% +$2.37K 0.69% 42
2019
Q1
$2.88M Buy
31,601
+3,463
+12% +$310K 0.66% 43
2018
Q4
$2.56M Buy
28,138
+9,755
+53% +$912K 0.69% 43
2018
Q3
$1.81M Buy
18,383
+544
+3% +$50.3K 0.41% 73
2018
Q2
$1.53M Sell
17,839
-190
-1% -$15.9K 0.38% 83
2018
Q1
$1.45M Buy
18,029
+600
+3% +$49.5K 0.37% 85
2017
Q4
$1.41M Buy
17,429
+160
+0.9% +$12.8K 0.36% 88
2017
Q3
$1.34M Buy
17,269
+705
+4% +$58.5K 0.41% 77
2017
Q2
$1.47M Hold
16,564
0.46% 63
2017
Q1
$1.33M Buy
16,564
+741
+5% +$57.9K 0.42% 69
2016
Q4
$1.13M Sell
15,823
-200
-1% -$15.7K 0.37% 78
2016
Q3
$1.38M Sell
16,023
-150
-0.9% -$13.1K 0.48% 63
2016
Q2
$1.4M Hold
16,173
0.5% 57
2016
Q1
$1.21M Buy
16,173
+400
+3% +$30.1K 0.45% 64
2015
Q4
$1.21M Sell
15,773
-1,014
-6% -$76.3K 0.45% 65
2015
Q3
$1.12M Sell
16,787
-2,200
-12% -$162K 0.44% 71
2015
Q2
$1.41M Sell
18,987
-3,510
-16% -$268K 0.49% 57
2015
Q1
$1.75M Buy
22,497
+9,467
+73% +$718K 0.57% 50
2014
Q4
$941K Hold
13,030
0.31% 101
2014
Q3
$807K Sell
13,030
-300
-2% -$19.1K 0.28% 114
2014
Q2
$850K Buy
13,330
+1,200
+10% +$72.9K 0.28% 110
2014
Q1
$746K Hold
12,130
0.26% 109
2013
Q4
$696K Sell
12,130
-196
-2% -$11.1K 0.25% 115
2013
Q3
$656K Sell
12,326
-2,200
-15% -$118K 0.27% 113
2013
Q2
$748K Buy
+14,526
New +$718K 0.29% 104

Other funds holding MDT

Duncker Streett & Co's MDT Position: Q1 2026 in Review

Duncker Streett & Co reduced its Medtronic (MDT) stake by 1.7% in Q1 2026, selling an estimated $3.16K and leaving 1,876 shares worth $163K. The position accounts for 0.03% of the portfolio, ranked #247.

Duncker Streett & Co first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.69M in Q4 2020. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Duncker Streett & Co held 1,876 shares of Medtronic worth $163K as of Q1 2026.
  • Duncker Streett & Co sold 33 Medtronic shares in Q1 2026, an estimated $3.16K.
  • Medtronic made up 0.03% of Duncker Streett & Co's portfolio in Q1 2026, its #247 holding.
  • Duncker Streett & Co first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Duncker Streett & Co's Medtronic position peaked at $3.69M in Q4 2020.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.